Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Revenio Group Oyj is a Finnish health technology company and a global leader in ophthalmological devices and software solutions. It develops and commercializes effective, easy-to-use screening devices for detecting significant public health diseases, particularly in eye care. Its flagship offerings under the iCare brand include intraocular pressure (IOP) measurement devices known as tonometers, perimeter and fundus imaging devices, and the Oculo eye care software platform, which supports clinical communication, telehealth, remote patient monitoring, and data analytics. These tools aid physicians in diagnosing conditions such as glaucoma, diabetic retinopathy, and macular degeneration (AMD), enhancing efficiency and quality in ophthalmic diagnostics. Headquartered in Vantaa, Finland, Revenio Group Oyj operates through subsidiaries across regions including Finland, the USA, Italy, Australia, the UK, China, and the Netherlands, serving healthcare professionals worldwide in the medical devices sector.